Based in the Netherlands · Serving hospitals across Europe

Expert dosimetry planning for radioembolization

CuraDose provides Y-90 SIRT treatment planning as a service - enabling hospitals to offer radioembolization with expert-level dosimetry, without building in-house capacity.

GDPR Compliant EU-Hosted Infrastructure End-to-End Encrypted
portal.curadose.io
CuraDose Physician Portal

Dosimetry planning,
delivered to your portal

Hospitals submit cases through our secure physician portal. Our expert team handles the rest - from DICOM analysis to personalized treatment plans.

Case Submission

Physicians upload DICOM imaging and clinical data through our secure portal. Automated pseudonymization ensures patient privacy from the moment of upload.

Expert Planning

Our dosimetrists create personalized treatment plans using FDA-cleared, CE-approved calculation software - with rigorous quality assurance at every step.

Plan Delivery

Completed treatment plans are delivered back through the portal with full dosimetry reports - ready for physician review and clinical use.

Deep expertise across
clinical practice and technology

CuraDose combines decades of experience in interventional oncology, nuclear medicine, and medical device R&D.

CEO

Chief Executive Officer

Commercial & Clinical Strategy

Former Global Medical Director at a leading medical device company, with extensive experience in interventional oncology market development.

CMO

Chief Medical Officer

Clinical & Academic Leadership

Professor of Nuclear Medicine at UMC Utrecht, bringing world-class clinical expertise in radioembolization and nuclear medicine.

CTO

Chief Technology Officer

Platform & Product

Background in radiotherapy (Erasmus MC, Elekta) and medical devices (Global R&D Director). Architect of the CuraDose platform.

Ready to explore
dosimetry as a service?

Whether you are a hospital looking to start a radioembolization program or a vendor exploring partnership opportunities - we would love to hear from you.